Anti-Mullerian Hormone Treatment

solves

Oviva Therapeutics is a biotech startup aiming to revolutionize the way menopause is managed by delaying or potentially ending it. By focusing on preserving ovarian function through the manipulation of anti-Mullerian hormone, Oviva seeks to improve the quality of life for women facing midlife transitions.

Basic information
Country
USA
Group Name
Oviva Therapeutics
Source
Source

Log in to view more details.

Login